ArticleLifetime data analysis2017
Generalized accelerated failure time spatial frailty model for arbitrarily censored data.
Article in Lifetime data analysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- A Bayesian spline-augmented piecewise exponential model with spatial frailty for under-five mortality in Nigeria.Frontiers in epidemiology · 2026Article
- Geospatial Variation and Determinants of Time to Pregnancy Loss Among Reproductive-Aged Women in East Africa: Bayesian Spatial Frailty Model.BioMed research international · 2026Article
- Fast Variational Bayesian Inference for Correlated Survival Data: An Application to Invasive Mechanical Ventilation Duration Analysis.Statistics in medicine · 2025Article
- Characterizing quantile-varying covariate effects under the accelerated failure time model.Biostatistics (Oxford, England) · 2024Article
- Spatial-temporal Bayesian accelerated failure time models for survival endpoints with applications to prostate cancer registry data.BMC medical research methodology · 2024Article
- A flexible parametric approach for analyzing arbitrarily censored data that are potentially subject to left truncation under the proportional hazards model.Lifetime data analysis · 2023Article
- Bayes factors for choosing among six common survival models.Lifetime data analysis · 2019Article
- SSR marker-assisted screening of commercial tomato genotypes under salt stress.Breeding science · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Flexible incorporation of both geographical patterning and risk effects in cancer survival models is becoming increasingly important, due in part to the recent availability of large cancer registries. Most spatial survival models stochastically order survival curves from different subpopulations. However, it is common for survival curves from two subpopulations to cross in epidemiological cancer studies and thus interpretable standard survival models can not be used without some modification. Common fixes are the inclusion of time-varying regression effects in the proportional hazards model or fully nonparametric modeling, either of which destroys any easy interpretability from the fitted model. To address this issue, we develop a generalized accelerated failure time model which allows stratification on continuous or categorical covariates, as well as providing per-variable tests for whether stratification is necessary via novel approximate Bayes factors. The model is interpretable in terms of how median survival changes and is able to capture crossing survival curves in the presence of spatial correlation. A detailed Markov chain Monte Carlo algorithm is presented for posterior inference and a freely available function frailtyGAFT is provided to fit the model in the R package spBayesSurv. We apply our approach to a subset of the prostate cancer data gathered for Louisiana by the surveillance, epidemiology, and end results program of the National Cancer Institute.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.